At ABINITIO we accelerate your path from molecule to market. Through our Science • Scale • Success (3S) framework, we bring together R&D, GMP manufacturing, and CRO clinical trial services into a single, coordinated platform—so development moves forward with clarity, efficiency, and control. We specialise in complex dosage forms, including inhaled, intranasal, oral, and advanced drug delivery systems, supporting both small and large molecules. Our capabilities span formulation development, analytical method development and validation, GMP manufacturing of clinical trial materials, and full-service clinical trial execution. By aligning R&D, manufacturing, and clinical execution from the outset, we reduce development risk, streamline timelines, and enable efficient progression into human studies.
| Website | https://abinitio.com.au/ |
| Employees | 20 (7 on RocketReach) |
| Founded | 2019 |
| Industry | Pharmaceutical Manufacturing |
Looking for a particular ABINITIO employee's phone or email?
Paul Young is the CEO of ABINITIO.
7 people are employed at ABINITIO.
ABINITIO is based in Camperdown, New South Wales.